Express News | Pharma Mar - Reaches Commercial Milestone About Yondelis (Trabectedin) in United States
Is Johnson & Johnson (JNJ) the Best Pharma Stock to Buy Right Now?
Empower 2024 Delivers Groundbreaking Insights and Innovation to Achieve Data-Driven Healthcare
Alvotech, Advanz's Application for AVT05 Accepted by European Medicines Agency
New Study Reveals Another Benefit in Using Novo Nordisk's Wegovy in Obesity
Express News | The results of the national medical insurance negotiations are expected to be released at the end of November 2024.